Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Microba Life Sciences Limited ( (AU:MAP) ) has issued an update.
Microba Life Sciences Limited has announced its 2025 Annual General Meeting (AGM), inviting shareholders to participate either in person or by proxy. The AGM will be held on November 19, 2025, in Brisbane, and shareholders are encouraged to submit questions in advance. The company emphasizes the importance of electronic communication, urging shareholders to update their communication preferences to receive important documents and updates efficiently. This move aligns with Microba’s commitment to enhancing stakeholder engagement and operational transparency.
The most recent analyst rating on (AU:MAP) stock is a Buy with a A$0.19 price target. To see the full list of analyst forecasts on Microba Life Sciences Limited stock, see the AU:MAP Stock Forecast page.
More about Microba Life Sciences Limited
Microba Life Sciences is a precision microbiome company focused on improving human health. The company utilizes advanced technology to measure the human gut microbiome, aiming to discover and develop novel therapeutics for major chronic diseases. It also provides gut microbiome testing services globally to researchers, clinicians, and consumers, and collaborates with leading organizations to explore new health solutions.
Average Trading Volume: 546,733
Technical Sentiment Signal: Sell
Current Market Cap: A$51.76M
See more insights into MAP stock on TipRanks’ Stock Analysis page.